Scientists are testing an experimental anti-amyloid antibody in people expected to develop early-onset Alzheimer’s.
Can a Drug Prevent Alzheimer’s Disease Decades Before It Happens? (Links to an external site)
Category: Advancements in Alzheimers disease
New drug targets for Alzheimer’s identified from cerebrospinal fluid (Links to an external site)
Study pegs certain cellular activities to driving Alzheimer’s disease. Researchers at Washington University School of Medicine in St. Louis have linked disease-related proteins and genes to identify specific cellular pathways responsible for Alzheimer’s genesis and progression.
The New Age of Alzheimer’s (Links to an external site)
The soaring burden of dementia threatens global health. Science is paving new paths to solutions.
Podcast: Newly approved drug may slow progression of Alzheimer’s (Links to an external site)
Lilly drug slows Alzheimer’s by 35%, bolstering treatment approach (Links to an external site)
Conquering Alzheimer’s: a look at the therapies of the future (Links to an external site)
Focused ultrasound technique leads to release of neurodegenerative disorders biomarkers (Links to an external site)
FDA APPROVES LEQEMBI™ (LECANEMAB-IRMB) UNDER THE ACCELERATED APPROVAL PATHWAY FOR THE TREATMENT OF ALZHEIMER’S DISEASE (Links to an external site)
WashU, Eisai form drug discovery collaboration (Links to an external site)
